Home / Private raises / Matchpoint Therapeutics Inc.

Matchpoint Therapeutics Inc.

Pharmaceuticals · Watertown, Massachusetts · $68.4M sold across 1 offering

Form D filings (1)

FiledFormSoldOfferedInvestorsExemptionSecuritiesFirst sale
2026-11-20D (new)$68.4M$150M22506(b)EquityOct 1SEC ↗

An update (D/A) restates the running total of its offering, so the total above counts each offering's latest figure once.

Issuer

IndustryPharmaceuticals
LocatedWatertown, Massachusetts
EntityCorporation
IncorporatedDelaware, 2021
SEC CIK1950915

People named in the latest filing

NameRole
Andre TurenneExecutive Officer, Director
Brian MatesicDirector
Kanishka PothulaDirector
Jason HaflerDirector
Bruce BoothDirector
Daniel BeckerDirector
Donald NicolsonDirector
Jared CummingExecutive Officer
John O'MalleyExecutive Officer

Names and roles as filed with the SEC. Addresses are not shown.

Source: SEC EDGAR Form D filings. Amounts are self-reported by the issuer. Not investment advice.

How are we doing?